U.S. Health and Human Services (HHS) Secretary Xavier Becerra said yesterday that “we’re going to continue to fight” drug manufacturers that restrict 340B pricing when covered entities use contract pharmacies “because it’s the law.”
Becerra’s Feb. 14 remarks about manufacturers’ actions, made at the National Association of Community Health Centers’ (NACHC) 2022 Policy & Issues (P&I) Virtual Forum, came soon after GlaxoSmithKline announced conditions on 340B pricing when hospitals use contract pharmacies to dispense nine of its respiratory medicines. GSK’s new policy exempts health centers and other grantee 340B entities. Eleven of the 14 manufacturers with restrictive 340B contract pharmacy policies target hospitals only.
U.S. Health and Human Services (HHS) Secretary Xavier Becerra said yesterday that “we’re going to continue to fight” drug manufacturers that restrict 340B pricing when covered entities use contract pharmacies “because it’s the law.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.